1. Home
  2. AMBA vs BLCO Comparison

AMBA vs BLCO Comparison

Compare AMBA & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBA
  • BLCO
  • Stock Information
  • Founded
  • AMBA 2004
  • BLCO 1853
  • Country
  • AMBA United States
  • BLCO Canada
  • Employees
  • AMBA N/A
  • BLCO N/A
  • Industry
  • AMBA Semiconductors
  • BLCO Ophthalmic Goods
  • Sector
  • AMBA Technology
  • BLCO Health Care
  • Exchange
  • AMBA Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • AMBA 3.3B
  • BLCO 4.0B
  • IPO Year
  • AMBA N/A
  • BLCO 2022
  • Fundamental
  • Price
  • AMBA $52.64
  • BLCO $11.45
  • Analyst Decision
  • AMBA Buy
  • BLCO Hold
  • Analyst Count
  • AMBA 12
  • BLCO 12
  • Target Price
  • AMBA $80.83
  • BLCO $15.59
  • AVG Volume (30 Days)
  • AMBA 856.7K
  • BLCO 865.4K
  • Earning Date
  • AMBA 05-29-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • AMBA N/A
  • BLCO N/A
  • EPS Growth
  • AMBA N/A
  • BLCO N/A
  • EPS
  • AMBA N/A
  • BLCO N/A
  • Revenue
  • AMBA $316,264,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • AMBA $20.37
  • BLCO $6.97
  • Revenue Next Year
  • AMBA $11.56
  • BLCO $5.44
  • P/E Ratio
  • AMBA N/A
  • BLCO N/A
  • Revenue Growth
  • AMBA 44.54
  • BLCO 11.94
  • 52 Week Low
  • AMBA $38.86
  • BLCO $10.45
  • 52 Week High
  • AMBA $85.15
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • AMBA 39.68
  • BLCO 44.25
  • Support Level
  • AMBA $60.88
  • BLCO $10.99
  • Resistance Level
  • AMBA $63.64
  • BLCO $12.05
  • Average True Range (ATR)
  • AMBA 2.56
  • BLCO 0.41
  • MACD
  • AMBA -0.67
  • BLCO 0.08
  • Stochastic Oscillator
  • AMBA 13.48
  • BLCO 35.38

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: